Date: 2014-02-27
Type of information: Private placement
Company: Santhera Pharmaceuticals (Switzerland)
Investors: IGLU Group (Switzerland)
Amount: CHF 1 Million (€ 0.8 million)
Funding type: private placement
Planned used:
Others: * On February 27, 2014, Santhera Pharmaceuticals has announced it raised CHF 1 million in a private placement with IGLU Group AG, Zug, Switzerland. Santhera sold 288,317 registered company shares at a price of CHF 3.47 per share, representing a 8% discount to the lowest volume-weighted average share price of the last five trading days. The newly issued shares have a lock-up period of 100 days. The transaction further strengthens Santhera\'s financial flexibility.The private placement agreement was signed on February 26, 2014 after the close of trading on the SIX Swiss Exchange. The new shares with a par value of CHF 1.00 each will be issued from the Company\'s authorized share capital and will represent 6.3% of the outstanding share capital of CHF 4,578,521 after the transaction. The subscription rights of existing shareholders have been excluded in accordance with Santhera\'s articles of incorporation. The new shares will be listed on the SIX Swiss Exchange on February 28, 2014. IGLU Group has agreed to a lock-up with regard to the new shares for a period of 100 days following the share issuance.
Therapeutic area: Neuromuscular diseases - Rare diseases
